CONMED (CNMD)
(Real Time Quote from BATS)
$76.50 USD
+0.49 (0.65%)
Updated Sep 19, 2024 10:36 AM ET
4-Sell of 5 4
B Value B Growth B Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CNMD 76.50 +0.49(0.65%)
Will CNMD be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CNMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CNMD
New Strong Sell Stocks for September 17th
New Strong Sell Stocks for September 11th
CNMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Is Conmed (CNMD) Up 13.2% Since Last Earnings Report?
Do Options Traders Know Something About CONMED (CNMD) Stock We Don't?
New Strong Sell Stocks for August 19th
Other News for CNMD
Conmed Performance Analysis: Hold Rating Justified Amid Supply Chain Resolutions and Gross Margin Adjustments
CONMED Corporation to Participate in a Virtual Fireside Chat at the CL King Best Ideas Conference
How To YieldBoost CNMD To 15.5% Using Options
Baird Q2 2024 Small/Mid Cap Growth Equity Fund Commentary
CONMED Corporation to Participate in a Fireside Chat at the Wells Fargo Healthcare Conference